The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy
Open accessAbstract
Background Low muscle mass (LMM) and low muscle attenuation (LMA) reflect low muscle quantity and low muscle quality, respectively. Both are associated with a poor outcome in several types of solid malignancies. This study determined the association of skeletal muscle measures with overall survival (OS) and time to next treatment (TNT). Patients and methods A skeletal muscle index (SMI) in cm 2 /m 2 and muscle attenuation (MA) in Hounsfield units (HU) were measured using abdominal CT-images of 166 patients before start of first-line chemotherapy for metastatic breast cancer. Low muscle mass (SMI <41 cm 2 /m 2 ), sarcopenic obesity (LMM and BMI ≥30 kg/m 2 ) and low muscle attenuation (MA <41 HU and BMI <25 kg/m2 or MA <33 HU and BMI ≥25 kg/m2) were related to OS and TNT. Results The prevalence of LMM, sarcopenic obesity and LMA were 66.9%, 7.2% and 59.6% respectively. LMM and sarcopenic obesity showed no significant association with OS and TNT, whereas LMA was associated with both lower OS (HR 2.04, 95% CI 1.34–3.12, p = 0.001) and shorter TNT (HR 1.72, 95% CI 1.14–2.62, p = 0.010). Patients with LMA had a median OS and TNT of 15 and 8 months respectively, compared to 23 and 10 months in patients with normal MA. Conclusion LMA is a prognostic factor for OS and TNT in metastatic breast cancer patients receiving first-line palliative chemotherapy, whereas LMM and sarcopenic obesity are not. Further research is needed to establish what impact LMA should have in daily clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“reported associations indicate a stronger link of muscle fat with adverse outcomes as compared with muscle quantity.60,61,[65][66][67]”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R. A., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,761
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study
Goodpaster, B. H., Carlson, C. L., Visser, M., Kelley, D. E., Scherzinger, A., Harris, T. B., Stamm, E., & Newman, A. B. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.6.2157 · Cited by 1,226
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K. S., Mackey, J. R., Koski, S. L., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,125
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shachar, S. S., Williams, G. R., Muss, H. B., & Nishijima, T. F. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.030 · Cited by 1,125
Delmonico, M. J., Harris, T. B., Lee, J., Visser, M., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Newman, A. B., & for the Health, A. A. B. C. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01140.x · Cited by 819
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
Aubrey, J., Esfandiari, N., Baracos, V. E., Buteau, F. A., Frenette, J., Putman, C. T., & Mazurak, V. C. (2014) · Acta Physiologica · doi:10.1111/apha.12224 · Cited by 720
Fujiwara, N., Nakagawa, H., Kudo, Y., Tateishi, R., Taguri, M., Watadani, T., Nakagomi, R., Kondo, M., Nakatsuka, T., Minami, T., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.031 · Cited by 713
Landi, F., Cruz-Jentoft, A. J., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2013) · Age and Ageing · doi:10.1093/ageing/afs194 · Cited by 619
Batsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479
Cao, L., & Morley, J. E. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.06.001 · Cited by 424 · cited 1×
“In several diseases there is an association between low muscle mass and outcome, irrespective of the exact underlying mechanism [2].”
Mir, O., Coriat, R., Blanchet, B., Durand, J.-P., Boudou, P., Michels, J., Ropert, S., Vidal, M., Pol, S., Chaussade, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037563 · Cited by 304
Tan, B. H. L., Brammer, K., Randhawa, N., Welch, N. T., Parsons, S. L., James, E., & Catton, J. A. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.11.040 · Cited by 285
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Awad, S., Tan, B. H. L., Cui, H. W., Bhalla, A., Fearon, K. C. H., Parsons, S. L., Catton, J. A., & Lobo, D. N. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.08.008 · Cited by 276
Mortality as an adverse outcome of sarcopenia
Arango-Lopera, V. E., Arroyo, P., Gutiérrez‐Robledo, L. M., Pérez‐Zepeda, M. U., & Cesari, M. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0434-0 · Cited by 269
Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
Barret, M., Antoun, S., Dalban, C., Malka, D., Mansourbakht, T., Zaanan, A., Latko, E., & Taïeb, J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.894103 · Cited by 248
Meza–Junco, J., Montaño‐Loza, A. J., Baracos, V. E., Prado, C. M. M., Bain, V. G., Beaumont, C., Esfandiari, N., Lieffers, J. R. L., & Sawyer, M. B. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318293a825 · Cited by 248
Choi, Y., Oh, D., Kim, T., Lee, K.-H., Han, S., Im, S., Kim, T., & Bang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139749 · Cited by 247
Huang, D., Wang, S., Zhuang, C., Zheng, B. ‐., Lu, J. ‐., Chen, F., Zhou, C.-J., Shen, X., & Zhao, Y. (2015) · Colorectal Disease · doi:10.1111/codi.13067 · Cited by 244
Rier, H. N., Jager, A., Sleijfer, S., Maier, A. B., & Levin, M. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0066 · Cited by 233
Self-citationYip, C., Goh, V., Davies, A., Gossage, J., Mitchell-Hay, R., Hynes, O., Maisey, N. R., Ross, P. J., Gaya, A. M., Landau, D., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3110-4 · Cited by 227
Antoun, S., Lanoy, É., Iacovelli, R., Albiges, L. K., Loriot, Y., Merad-Taoufik, M., Fizazi, K. S., Palma, M. D., Baracos, V. E., & Escudier, B. J. (2013) · Cancer · doi:10.1002/cncr.28218 · Cited by 224
Tamandl, D., Paireder, M., Asari, R., Baltzer, P., SCHOPPMANN, S. F., & Ba‐Ssalamah, A. (2015) · European Radiology · doi:10.1007/s00330-015-3963-1 · Cited by 211
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
Stene, G. B., Helbostad, J. L., Amundsen, T., Sørhaug, S., Hjelde, H. H., Kaasa, S., & Grønberg, B. H. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.953259 · Cited by 209
Wang, S.-L., Zhuang, C., Huang, D., Pang, W., Lou, N., Chen, F., Zhou, C.-J., Shen, X., & Yu, Z. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4887-3 · Cited by 201
Johns, N., Stephens, N. A., & Fearon, K. C. H. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.032 · Cited by 196
Joglekar, S., Nau, P. N., & Mezhir, J. J. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24025 · Cited by 194
Adams, S. C., SEGAL, R. J., McKenzie, D. C., Vallerand, J. R., Morielli, A. R., Mackey, J. R., Gelmon, K. A., Friedenreich, C. M., Reid, R. D., & Courneya, K. S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3900-2 · Cited by 191
Rolland, Y., van Kan, G. A., Guyonnet, S., & Vellas, B. J. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328340c2c2 · Cited by 161
Cooper, A. B., Slack, R. S., Fogelman, D. R., Holmes, H. M., Petzel, M. Q. B., Parker, N. H., Balachandran, A., Garg, N., Ngo‐Huang, A., Varadhachary, G. R., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4285-2 · Cited by 159
Lanic, H., Kraut-Tauzia, J., Modzelewski, R., Clatot, F., Mareschal, S., Picquenot, J. M., Stamatoullas, A., Leprêtre, S., Tilly, H., & Jardin, F. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.816421 · Cited by 155
Miyamoto, Y., Baba, Y., Sakamoto, Y., Ohuchi, M., Tokunaga, R., Kurashige, J., Hiyoshi, Y., Iwagami, S., Yoshida, N., Watanabe, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129742 · Cited by 147
Camus, V., Lanic, H., Kraut, J., Modzelewski, R., Clatot, F., Picquenot, J. M., Contentin, N., Lenain, P., Groza, L., Lemasle, É., et al. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12285 · Cited by 133
Hayashi, N., Ando, Y., Gyawali, B., Shimokata, T., Maeda, O., Fukaya, M., Goto, H., Nagino, M., & Kodera, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4475 · Cited by 99
Rolland, Y., Gallini, A., Cristini, C., Schott, A., Blain, H., Beauchet, O., Cesari, M., & Lauwers‐Cancès, V. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086728 · Cited by 64
Akahori, T., Sho, M., Kinoshita, S., Nagai, M., Nishiwada, S., Tanaka, T., Tamamoto, T., Ohbayashi, C., Hasegawa, M., Kichikawa, K., et al. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3205-3 · Cited by 63
Kitamura, I., Koda, M., Otsuka, R., Ando, F., & Shimokata, H. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12109 · Cited by 51
Research works printed but not linked: 1
- Cruz-Jentoft, 2014, Prevalence of and interventions for sarcopenia in ageing adults: a systematic review, Rep Int Sarcopenia Initiat. EWGSOP IWGS, 43, 748
Cited by
Sorted by citations
Caan, B. J., Feliciano, E. M. C., Prado, C. M. M., Alexeeff, S., Kroenke, C. H., Bradshaw, P. T., Quesenberry, C. P., Weltzien, E. K., Castillo, A., Olobatuyi, T. A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0137 · Cited by 583
Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391
Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review
Amini, B., Boyle, S. P., Boutin, R. D., & Lenchik, L. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz034 · Cited by 391
Baracos, V. E., & Arribas, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx810 · Cited by 362
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
Aleixo, G. F. P., Shachar, S. S., Nyrop, K. A., Muss, H. B., Malpica, L., & Williams, G. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102839 · Cited by 347
Metadata
- Authors
- Rier, H. N., Jager, A., Sleijfer, S., van Rosmalen, J., Kock, M. C. J. M., & Levin, M.-D.
- Affiliations
- Albert Schweitzer Ziekenhuis (NL)
- Erasmus MC Cancer Institute (NL)
- Erasmus MC (NL)
- Corresponding author
- Rier, Hánah N.
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 31
- Pages
- 9-15
- ISSN
- 0960-9776 (ISSN-L)
- OpenAlex
- W2540033076
- Cited by
- 149
- References
- 42
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 20 · 2023: 14 · 2022: 18 · 2021: 25 · 2020: 20 · 2019: 16 · 2018: 16 · 2017: 5
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Keywords
- metastatic breast cancer, skeletal muscle index, sarcopenic obesity, low muscle mass, prognostic factors, overall survival, time to next treatment, palliative chemotherapy, skeletal muscle quality, sarcopenia
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Female, Humans, Middle Aged, Muscular Atrophy, Neoplasm Metastasis, Netherlands, Palliative Care, Prognosis, Retrospective Studies, Tomography, X-Ray Computed, Prevalence, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
